Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in Spain

  1. Calvo Aller, E.
  2. Maroto, P.
  3. Kreif, N.
  4. González Larriba, J.L.
  5. López-Brea, M.
  6. Castellano, D.
  7. Martí, B.
  8. Díaz Cerezo, S.
Aldizkaria:
Clinical and Translational Oncology

ISSN: 1699-048X,  1699-3055

Argitalpen urtea: 2011

Alea: 13

Zenbakia: 12

Orrialdeak: 869-877

Mota: Artikulua

DOI: 10.1007/S12094-011-0748-0 GOOGLE SCHOLAR
Datuen iturria: Scopus